Alberta Investment Management Corp (AIMCo)’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,000
Closed -$1.8M 814
2025
Q4
$1.8M Buy
+25,000
New +$1.61M 0.01% 487

Other funds holding RNAM

Alberta Investment Management Corp (AIMCo)'s RNAM Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 25,000 shares — an estimated $1.8M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.8M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 25,000 Avidity Biosciences shares in Q1 2026, an estimated $1.8M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Avidity Biosciences position peaked at $1.8M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.